While industry funding plateaued last year, significant shifts were seen in allocation, with millions more in support for certified med ed going to publishing/education companies.
Editors Marc Iskowitz and Larry Dobrow unpack MM&M’s Agency 100 issue in this edited transcript of their conversation for The MM&M Podcast.
After its setback in the Oklahoma opioid trial, J&J should compromise rather than face judgment.
The company’s failed bid to have the Oklahoma opioid case tossed was followed this week by a reported criminal probe into its talcum baby powder.
Agencies shrug off any concerns about drug pricing as revenue among the Agency 100 climbs by 16% in 2018, hitting $3.3 billion.
W2O revenue rose 21.8% in 2018, to $162 million from 2017’s total of $133 million.
Ogilvy Health emerged from 2018 with a new leader, a new name and a head start towards integrating with parent company Ogilvy.
Revenue shot up 20.1% to $287 million in 2018, from $239 million the year prior.
Dudnyk boosted revenue by 22.5%, from $16.9 million in 2017 to $20.7 million.
Following the close of live judging for the 2019 MM&M Awards, MM&M’s Marc Iskowitz caught up with this year’s jury chair, April Mitchell of Otsuka, for a debrief. This is an edited transcript of their interview.
